AcousticaBio
Cambridge
About AcousticaBio
AcousticaBio is a company that has developed a means to reformulate intravenous medications so they can be administered via an injection under the skin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $150.0K
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2022)
- Website: acoustica.bio
- Phone: [email protected]
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/acousticabio-98400 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.